2015-2027 Global Insulin Active Pharmaceutical Ingredient Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 122 pages | ID: 2B173947B262EN
Maia Research

Abstracts

The worldwide market for Insulin Active Pharmaceutical Ingredient is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Tong Hua Dong Bao Group
Novo Nordisk
Wanbang Biopharmaceuticals
Eli Lilly

Major Types Covered
Chemical Synthetics
Animal Extracts

Major Applications Covered
Animal Insulin
Regular Human Insulin
Insulin Analogue

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Insulin Active Pharmaceutical Ingredient Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Insulin Active Pharmaceutical Ingredient Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE INSULIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL INSULIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY TYPE

5.1 Chemical Synthetics
5.2 Animal Extracts

6 GLOBAL INSULIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY APPLICATION

6.1 Animal Insulin
6.2 Regular Human Insulin
6.3 Insulin Analogue

7 GLOBAL INSULIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Tong Hua Dong Bao Group
  8.1.1 Tong Hua Dong Bao Group Profile
  8.1.2 Tong Hua Dong Bao Group Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Tong Hua Dong Bao Group Product/Solution Launches and Enhancements Analysis
  8.1.4 Tong Hua Dong Bao Group Business Overview/Recent Development/Acquisitions
8.2 Novo Nordisk
  8.2.1 Novo Nordisk Profile
  8.2.2 Novo Nordisk Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Novo Nordisk Product/Solution Launches and Enhancements Analysis
  8.2.4 Novo Nordisk Business Overview/Recent Development/Acquisitions
8.3 Wanbang Biopharmaceuticals
  8.3.1 Wanbang Biopharmaceuticals Profile
  8.3.2 Wanbang Biopharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Wanbang Biopharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.3.4 Wanbang Biopharmaceuticals Business Overview/Recent Development/Acquisitions
8.4 Eli Lilly
  8.4.1 Eli Lilly Profile
  8.4.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
  8.4.4 Eli Lilly Business Overview/Recent Development/Acquisitions

9 GLOBAL INSULIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Insulin Active Pharmaceutical Ingredient Production Analysis from 2015-2020
10.4 North America Insulin Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
10.5 North America Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
10.6 North America Insulin Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
10.7 North America Insulin Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Insulin Active Pharmaceutical Ingredient by Country (United States, Canada)
  10.8.1 North America Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  10.8.2 North America Insulin Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
10.9 North America Insulin Active Pharmaceutical Ingredient Market PEST Analysis

11 EUROPE

11.1 Europe Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Insulin Active Pharmaceutical Ingredient Production Analysis from 2015-2020
11.4 Europe Insulin Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
11.5 Europe Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
11.6 Europe Insulin Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
11.7 Europe Insulin Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Insulin Active Pharmaceutical Ingredient by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  11.8.2 Europe Insulin Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
11.9 Europe Insulin Active Pharmaceutical Ingredient Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Insulin Active Pharmaceutical Ingredient Production Analysis from 2015-2020
12.4 Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
12.5 Asia-Pacific Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
12.6 Asia-Pacific Insulin Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Insulin Active Pharmaceutical Ingredient by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Insulin Active Pharmaceutical Ingredient Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Insulin Active Pharmaceutical Ingredient Production Analysis from 2015-2020
13.4 Latin America Insulin Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
13.5 Latin America Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
13.6 Latin America Insulin Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Insulin Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Insulin Active Pharmaceutical Ingredient by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  13.8.2 Latin America Insulin Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
13.9 Latin America Insulin Active Pharmaceutical Ingredient Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Insulin Active Pharmaceutical Ingredient Production Analysis from 2015-2020
14.4 Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption Analysis from 2015-2020
14.5 Middle East & Africa Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
14.6 Middle East & Africa Insulin Active Pharmaceutical Ingredient Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Insulin Active Pharmaceutical Ingredient by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Insulin Active Pharmaceutical Ingredient Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL INSULIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET FROM 2020-2027

15.1 Future Forecast of the Global Insulin Active Pharmaceutical Ingredient Market from 2020-2027 Segment by Region
15.2 Global Insulin Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Insulin Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Insulin Active Pharmaceutical Ingredient Market Value ($) and Growth Rate of Insulin Active Pharmaceutical Ingredient from 2015-2027
Global Insulin Active Pharmaceutical Ingredient Production and Growth Rate Segment by Product Type from 2015-2027
Global Insulin Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by Application from 2015-2027
Figure Insulin Active Pharmaceutical Ingredient Picture
Table Product Specifications of Insulin Active Pharmaceutical Ingredient
Table Driving Factors for this Market
Table Industry News of Insulin Active Pharmaceutical Ingredient Market
Figure Value Chain Status of Insulin Active Pharmaceutical Ingredient
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Insulin Active Pharmaceutical Ingredient Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Insulin Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Chemical Synthetics of Insulin Active Pharmaceutical Ingredient
Figure Animal Extracts of Insulin Active Pharmaceutical Ingredient
Table Global Insulin Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Insulin Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Animal Insulin of Insulin Active Pharmaceutical Ingredient
Figure Regular Human Insulin of Insulin Active Pharmaceutical Ingredient
Figure Insulin Analogue of Insulin Active Pharmaceutical Ingredient
Table Global Insulin Active Pharmaceutical Ingredient Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Insulin Active Pharmaceutical Ingredient Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Insulin Active Pharmaceutical Ingredient
Figure Online Channel of Insulin Active Pharmaceutical Ingredient
Table Tong Hua Dong Bao Group Profile (Company Name, Plants Distribution, Sales Region)
Figure Tong Hua Dong Bao Group Sales and Growth Rate from 2015-2020
Figure Tong Hua Dong Bao Group Revenue ($) and Global Market Share from 2015-2020
Table Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novo Nordisk Profile (Company Name, Plants Distribution, Sales Region)
Figure Novo Nordisk Sales and Growth Rate from 2015-2020
Figure Novo Nordisk Revenue ($) and Global Market Share from 2015-2020
Table Novo Nordisk Insulin Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Wanbang Biopharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Wanbang Biopharmaceuticals Sales and Growth Rate from 2015-2020
Figure Wanbang Biopharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2015-2020
Figure Eli Lilly Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly Insulin Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Insulin Active Pharmaceutical Ingredient Production Value ($) by Region from 2015-2020
Table Global Insulin Active Pharmaceutical Ingredient Production Value Share by Region from 2015-2020
Table Global Insulin Active Pharmaceutical Ingredient Production by Region from 2015-2020
Table Global Insulin Active Pharmaceutical Ingredient Consumption Value ($) by Region from 2015-2020
Table Global Insulin Active Pharmaceutical Ingredient Consumption by Region from 2015-2020
Table North America Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table North America Insulin Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table North America Insulin Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table North America Insulin Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table North America Insulin Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table North America Insulin Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure North America Insulin Active Pharmaceutical Ingredient Market PEST Analysis
Table Europe Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Europe Insulin Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Europe Insulin Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Europe Insulin Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Europe Insulin Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Europe Insulin Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Europe Insulin Active Pharmaceutical Ingredient Market PEST Analysis
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Asia-Pacific Insulin Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Insulin Active Pharmaceutical Ingredient Market PEST Analysis
Table Latin America Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Latin America Insulin Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Latin America Insulin Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Latin America Insulin Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Latin America Insulin Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Latin America Insulin Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Latin America Insulin Active Pharmaceutical Ingredient Market PEST Analysis
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Import and Export from 2015-2020
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption by Country (2015-2020)
Table Middle East & Africa Insulin Active Pharmaceutical Ingredient Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Insulin Active Pharmaceutical Ingredient Market PEST Analysis
Table Global Insulin Active Pharmaceutical Ingredient Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Insulin Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Region (2020-2027)
Table Global Insulin Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Insulin Active Pharmaceutical Ingredient Production and Growth Rate Forecast by Type (2020-2027)
Table Global Insulin Active Pharmaceutical Ingredient Consumption and Growth Rate Forecast by Application (2020-2027)